DecisionRx Revenue and Competitors

USA

Location

#5677

Growjo Ranking

Estimated Revenue & Valuation

  • DecisionRx's estimated annual revenue is currently $4.9M per year.(i)
  • DecisionRx's estimated revenue per employee is $245,700
  • DecisionRx's total funding is $10M.

Employee Data

  • DecisionRx has 20 Employees.(i)
  • DecisionRx grew their employee count by 11% last year.

DecisionRx's People

NameTitleEmail/Phone
1
President and Co-founderReveal Email/Phone
2
Product OwnerReveal Email/Phone
3
Chief Growth OfficerReveal Email/Phone
4
Chief Technology OfficerReveal Email/Phone
5
Chief Growth OfficerReveal Email/Phone
6
Chief Technology OfficerReveal Email/Phone
7
Director Product & EngineeringReveal Email/Phone
8
Director Patient ServicesReveal Email/Phone
9
Business Development SpecialistReveal Email/Phone
10
Senior Software EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$58.5M1978%N/AN/A
#2
$20.5M763%N/AN/A
#3
$202.5M60026%N/AN/A
#4
$44.8M1515%N/AN/A
#5
$34M1264%N/AN/A
#6
$34.8M1295%N/AN/A
#7
$42.8M14431%N/AN/A
#8
$16.2M69-22%$29.7MN/A
#9
$2131.5M563910%$9.3MN/A
#10
$56.4M19018%N/AN/A
Add Company

What Is DecisionRx?

Forty percent of prescriptions don't work as intended, and these medication failures comprise at least 16% of total healthcare spending. There is no larger avoidable cost incurred by any payor. \n\nDecisionRx guarantees reduced healthcare cost by reducing these medication failures. We do this using clinical pharmacists, data science, genomics, and a value-based workflow that makes it easy (not harder) for providers to deliver a higher standard of care. \n\nWe fund the entire cost of the program in exchange for a share of realized savings. We call this process Medication Therapy Optimization (MTO).

keywords:N/A

$10M

Total Funding

20

Number of Employees

$4.9M

Revenue (est)

11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.3M20-13%N/A
#2
$2M20-5%N/A
#3
$2M20N/AN/A
#4
$2M20N/AN/A
#5
$2M20N/AN/A